EPO Patents = 5

Forward Citations = 2

Loading Chart...

7 inventors (with patents filed for the assignee):

Henry Johnson (8 out of 13 patents)

Dustin L McMinn (7 out of 31 patents)

Sean Dalziel (6 out of 30 patents)

4. Evan Lewis (4 out of 6 patents)

5. John William Taunton (1 out of 5 patents)

6. Phillip Patrick Sharp (1 out of 4 patents)

7. Meera Rao (4 patents)

8. Dustin Mcminn (0 patent)

9. Dustin Mcminn (0 patent)

10 patents: Sort by Forward Citations

1. 12600711 - TRIAZACYCLODODECANSULFONAMIDE (TCD)-BASED PROTEIN SECRETION INHIBITORS (2026-04-14),

2. 12357638 - Immunoproteasome inhibitor formulations (2025-07-15),

3. 11976053 - Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof (2024-05-07),

4. 11891383 - Crystalline salts of peptide epoxyketone immunoproteasome inhibitor (2024-02-06),

5. 11578055 - Triazacyclododecansulfonamide ('TCD')-based protein secretion inhibitors (2023-02-14),

6. 11498907 - Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof (2022-11-15),

7. 11479548 - Crystalline salts of peptide epoxyketone immunoproteasome inhibitor (2022-10-25),

8. 11339193 - CDP protein secretion inhibitors (2022-05-24),

9. 10836756 - Crystalline salts of peptide epoxyketone immunoproteasome inhibitor (2020-11-17),

10. 10781192 - Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof (2020-09-22),

Company Overview

Kezar Life Sciences is a biopharmaceutical company based in South San Francisco, California, focused on the discovery and development of innovative therapies for unmet medical needs. The company specializes in advancing treatments for autoimmune diseases and cancer, leveraging its expertise in protein homeostasis and immunology. By utilizing a unique approach to drug development, Kezar aims to provide novel solutions that improve patient outcomes and address complex health challenges.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#105 in South San Francisco, CA

#7,118 in California

#29,882 in US

#56,092 in the World

South San Francisco, CA, United States of America

Kezar Life Sciences

Forward Citations = 2

7 inventors:

Henry Johnson (8 out of 13 patents)

Dustin L McMinn (7 out of 31 patents)

Sean Dalziel (6 out of 30 patents)

4. Evan Lewis (4 out of 6 patents)

5. John William Taunton (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kezar Life Sciences. Retrieved from https://idiyas.com/company/kezar-life-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]